MTERF1
Transcription termination factor 1, mitochondrial
Also known as: MTEF1_HUMAN, MTERF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99551
- Gene
- MTERF1
- Ensembl
- ENSG00000127989
- Chromosome
- 7
- Canonical length
- 399 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a mitochondrial transcription termination factor. This protein participates in attenuating transcription from the mitochondrial genome; this attenuation allows higher levels of expression of 16S ribosomal RNA relative to the tRNA gene downstream. The product of this gene has three leucine zipper motifs bracketed by two basic domains that are all required for DNA binding. There is evidence that, for this protein, the zippers participate in intramolecular interactions that establish the three-dimensional structure required for DNA binding. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
399 residues, UniProt reviewed canonical sequence.
>Q99551|MTERF1
1 MQSLSLGQTS ISKGLNYLTI MAPGNLWHMR NNFLFGSRCW MTRFSAENIF KSVSFRLFGV
61 KCHNTDSEPL KNEDLLKNLL TMGVDIDMAR KRQPGVFHRM ITNEQDLKMF LLSKGASKEV
121 IASIISRYPR AITRTPENLS KRWDLWRKIV TSDLEIVNIL ERSPESFFRS NNNLNLENNI
181 KFLYSVGLTR KCLCRLLTNA PRTFSNSLDL NKQMVEFLQA AGLSLGHNDP ADFVRKIIFK
241 NPFILIQSTK RVKANIEFLR STFNLNSEEL LVLICGPGAE ILDLSNDYAR RSYANIKEKL
301 FSLGCTEEEV QKFVLSYPDV IFLAEKKFND KIDCLMEENI SISQIIENPR VLDSSISTLK
361 SRIKELVNAG CNLSTLNITL LSWSKKRYEA KLKKLSRFALocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTERF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 13 nTPM
- tonsil: 12 nTPM
- thymus: 11 nTPM
- liver: 11 nTPM
- bone marrow: 9.5 nTPM
- spleen: 9.1 nTPM
Single-cell type
- oligodendrocytes: 174 nCPM
- distal convoluted tubule cells: 158 nCPM
- podocytes: 148 nCPM
- renal connecting tubule cells: 135 nCPM
- renal collecting duct intercalated cells: 129 nCPM
- pituitary stem cells: 120 nCPM
Immune cell
- basophil: 46 nTPM
- naive CD4 T-cell: 26 nTPM
- naive B-cell: 24 nTPM
- memory B-cell: 22 nTPM
- memory CD8 T-cell: 22 nTPM
- naive CD8 T-cell: 21 nTPM
Brain region
- white matter: 19 nTPM
- hypothalamus: 16 nTPM
- basal ganglia: 16 nTPM
- pons: 16 nTPM
- thalamus: 15 nTPM
- cerebellum: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA geometric change
- DNA-templated transcription termination
- termination of mitochondrial transcription
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTERF1 as an antibody target. Whether an autoantibody or antibody against MTERF1 could matter depends on whether native MTERF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTERF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTERF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...